This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodrigues, V.
Right arrow Articles by Dessein, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodrigues, V., Jr.
Right arrow Articles by Dessein, A. J.

 Previous Article  |  Next Article 

Infection and Immunity, September 1999, p. 4689-4692, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Genetic Control of Schistosome Infections by the SM1 Locus of the 5q31-q33 Region Is Linked to Differentiation of Type 2 Helper T Lymphocytes

Virmondes Rodrigues Jr.,1,2 Karen Piper,2 Patricia Couissinier-Paris,2 Olivia Bacelar,2 Hélia Dessein,2 and Alain J. Dessein2,*

Laboratorio de Imunologia, Faculdade de Medicina do Triangulo Mineiro, 30, Frei Paulino, 38025-160, Uberaba, MG, Brazil,1 and INSERM U399, Immunology and Genetic of Parasitic Diseases, Faculté de Médecine de Marseille, Université de la Méditerranée, Marseille, France2

Received 29 December 1998/Returned for modification 12 February 1999/Accepted 18 June 1999

Human susceptibility to Schistosoma mansoni infections is controlled by the SM1 locus on chromosome 5 in q31-q33. This genetic region encodes cytokines which regulate the development of helper T lymphocytes. In the present work, a clonal analysis of CD4+ T lymphocytes of homozygous resistant and homozygous susceptible subjects was undertaken to evaluate whether SM1 controls helper T-cell differentiation. Of 121 CD4+ T-cell clones (TCC) from three susceptible (S) and three resistant (R) subjects, 68 proliferated when stimulated by parasite antigens. Parasite-specific TCC derived from susceptible subjects (33 STCC) produced 10- to 1,000-fold less interleukin-4 and -5 than TCC from resistant subjects (25 RTCC). Clones from both patient groups produced, however, the same amount of gamma interferon. Parasite-specific STCC were type 1 helper (Th1) or Th0/1, whereas RTCC were either Th2 or Th0/2. These results, together with the localization of SM1 in 5q31-q33, indicate that the SM1 locus controls the differentiation of Th2 lymphocytes.


* Corresponding author. Mailing address: INSERM U399, Faculté de Médecine de Marseille, 27 Blvd. Jean Moulin, 13385 Marseille, Cedex 5, France. Phone: 04-91-32-44-53. Fax: 04-91-79-60-63. E-mail: Alain.Dessein{at}medecine.univ-mrs.fr.


Infection and Immunity, September 1999, p. 4689-4692, Vol. 67, No. 9
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Smith, P. M., Shainheit, M. G., Bazzone, L. E., Rutitzky, L. I., Poltorak, A., Stadecker, M. J. (2009). Genetic Control of Severe Egg-Induced Immunopathology and IL-17 Production in Murine Schistosomiasis. J. Immunol. 183: 3317-3323 [Abstract] [Full Text]  
  • Ellis, M. K., Zhao, Z. Z., Chen, H.-G., Montgomery, G. W., Li, Y.-S., McManus, D. P. (2007). Analysis of the 5q31 33 Locus Shows an Association between Single Nucleotide Polymorphism Variants in the IL-5 Gene and Symptomatic Infection with the Human Blood Fluke, Schistosoma japonicum. J. Immunol. 179: 8366-8371 [Abstract] [Full Text]  
  • Kouriba, B., Chevillard, C., Bream, J. H., Argiro, L., Dessein, H., Arnaud, V., Sangare, L., Dabo, A., Beavogui, A. H., Arama, C., Traore, H. A., Doumbo, O., Dessein, A. (2005). Analysis of the 5q31-q33 Locus Shows an Association between IL13-1055C/T IL-13-591A/G Polymorphisms and Schistosoma haematobium Infections. J. Immunol. 174: 6274-6281 [Abstract] [Full Text]  
  • Rutitzky, L. I., Hernandez, H. J., Yim, Y.-S., Ricklan, D. E., Finger, E., Mohan, C., Peter, I., Wakeland, E. K., Stadecker, M. J. (2005). Enhanced Egg-Induced Immunopathology Correlates With High IFN-{gamma} in Murine Schistosomiasis: Identification of Two Epistatic Genetic Intervals. J. Immunol. 174: 435-440 [Abstract] [Full Text]  
  • Fitzsimmons, C. M., Joseph, S., Jones, F. M., Reimert, C. M., Hoffmann, K. F., Kazibwe, F., Kimani, G., Mwatha, J. K., Ouma, J. H., Tukahebwa, E. M., Kariuki, Henry. C., Vennervald, B. J., Kabatereine, N. B., Dunne, D. W. (2004). Chemotherapy for Schistosomiasis in Ugandan Fishermen: Treatment Can Cause a Rapid Increase in Interleukin-5 Levels in Plasma but Decreased Levels of Eosinophilia and Worm-Specific Immunoglobulin E. Infect. Immun. 72: 4023-4030 [Abstract] [Full Text]  
  • Silva-Teixeira, D. N., Contigli, C., Lambertucci, J. R., Serufo, J. C., Rodrigues, V. Jr. (2004). Gender-Related Cytokine Patterns in Sera of Schistosomiasis Patients with Symmers' Fibrosis. CVI 11: 627-630 [Abstract] [Full Text]  
  • KING, C. H., BLANTON, R. E., MUCHIRI, E. M., OUMA, J. H., KARIUKI, H. C., MUNGAI, P., MAGAK, P., KADZO, H., IRERI, E., KOECH, D. K. (2004). LOW HERITABLE COMPONENT OF RISK FOR INFECTION INTENSITY AND INFECTION-ASSOCIATED DISEASE IN URINARY SCHISTOSOMIASIS AMONG WADIGO VILLAGE POPULATIONS IN COAST PROVINCE, KENYA. Am J Trop Med Hyg 70: 57-62 [Abstract] [Full Text]  
  • Ross, A. G.P., Bartley, P. B., Sleigh, A. C., Olds, G. R., Li, Y., Williams, G. M., McManus, D. P. (2002). Schistosomiasis. NEJM 346: 1212-1220 [Full Text]  
  • Ross, A. G. P., Sleigh, A. C., Li, Y., Davis, G. M., Williams, G. M., Jiang, Z., Feng, Z., McManus, D. P. (2001). Schistosomiasis in the People's Republic of China: Prospects and Challenges for the 21st Century. Clin. Microbiol. Rev. 14: 270-295 [Abstract] [Full Text]  
  • Dessein, Alain. J., Chevillard, C., Marquet, S., Henri, S., Hillaire, D., Dessein, H. (2001). Genetics of Parasitic Infections. Drug Metab. Dispos. 29: 484-488 [Abstract] [Full Text]